Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

0.8161
Delayed Data
As of 4:00pm ET
 -0.0129 / -1.56%
Today’s Change
0.73
Today|||52-Week Range
8.49
-35.23%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close0.83
Today’s open0.82
Day’s range0.81 - 0.83
Volume3,054,991
Average volume (3 months)6,341,746
Market cap$225.4M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.76%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SELBSelecta Biosciences ...-1.04-7.94%
CGENCompugen Ltd+0.07+1.89%
ENZYEnzymotec Ltd-0.25-2.82%
FATEFate Therapeutics In...-0.10-2.13%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts